-01KV75E8GE294THP0QNG4HFQMZ.png%3Fv%3D3&w=3840&q=75)
For research and educational purposes only. PepTalk discusses what researchers study in laboratory settings — not medical advice. Products are sold for laboratory research use only.
Research Peptide
Cagri
A long-acting amylin analog studied for metabolic and appetite-regulation research — freeze-dried, ultra-pure, ready to reconstitute.
Cagri is part of a research stack — 10% off every item plus free bacteriostatic water.
-01KV75E8GE294THP0QNG4HFQMZ.png%3Fv%3D3&w=96&q=75){kind=small}
For research and educational purposes only. PepTalk discusses what researchers study in laboratory settings — not medical advice. Products are sold for laboratory research use only.
The short version
Cagri is a synthetic, long-acting version of amylin — a hormone your pancreas releases alongside insulin every time you eat. What makes it interesting to researchers is that it works through a completely different channel than the GLP-1 compounds everyone talks about, which is why so much recent work pairs the two to see how the pathways add up.
What researchers are looking at
Amylin is one of the body's natural "you've eaten enough" signals. It's secreted together with insulin after a meal and acts in the brainstem to slow how fast the stomach empties and to dial back appetite. Cagri is an engineered mimic of that hormone, redesigned so it stays in circulation far longer than the natural version.
The key distinction researchers draw is the pathway. GLP-class compounds (like the incretin agonists) act on the GLP-1 receptor; Cagri does not. Instead it binds amylin and calcitonin receptors in the hindbrain — the area postrema and nucleus tractus solitarius — a separate, non-incretin route to the same downstream questions about satiety and food intake. Because the two mechanisms are independent, much of the literature studies them side by side.
Most of the foundational data here is preclinical, with the human work coming largely from combination studies. So the findings are best read as what researchers observe about the amylin pathway in the lab and early trials — not as proven outcomes — but the consistency of the satiety signal across models is what keeps it under scientific attention.
Amylin receptors engaged
Binds amylin and calcitonin receptors in the brainstem — a different target than GLP-1 compounds.
Gastric emptying slowed
Studied for how it decelerates stomach emptying, blunting the post-meal glucose rise.
Satiety signaled
The hindbrain satiation pathway is engaged, the focus of most food-intake research.
Where the evidence stands
an honest mapExtensive animal & obesity-model data
Phase 2/3 — mostly in combination studies
From the lab toward the clinic
Cagri has advanced into late-stage human trials, largely studied in combination with a GLP-1 agent (the CagriSema program) — a meaningful step from preclinical models toward rigorous human data on the amylin pathway.
At a glance
What it is
An amylin analog
long-acting
Pathway
Amylin / calcitonin
not GLP-1
Studied for
Satiety & metabolism
food-intake research
Research stage
In human trials
Phase 2/3
How it arrives
Lyophilized powder
Ships freeze-dried for stability and shelf life. Before research use, it's reconstituted with bacteriostatic water.
Bacteriostatic water
Needed to reconstitute
Certificate of analysis
Common questions
All products on FastPeps are labeled Research Use Only (RUO), and this is a legal requirement, not just fine print. It means these compounds are sold strictly for scientific research and laboratory purposes, not for personal use, self-administration, or medical treatment. This label exists because these compounds have not completed the FDA approval process to be sold as drugs or supplements. When you purchase from FastPeps, you are agreeing the product is for research purposes only.
For laboratory and research use only. Sold exclusively for in-vitro research and laboratory experimentation. Not a drug, supplement, or article intended for human or veterinary use; nothing here is medical advice or a claim of therapeutic benefit. Statements describe findings from published research.
Your Reliable Source for High-Quality Research Peptides
FastPeps is more than just a trusted U.S. supplier of research peptides. We are a catalyst for scientific advancement, dedicated to providing the highest quality peptides that empower our clients to push the boundaries of research.
